6 April 2026CompletedHealthcare
Neurocrine Biosciences, Inc. to acquire Soleno Therapeutics, Inc.
Neurocrine Biosciences, Inc. and Soleno Therapeutics, Inc. entered the Exit Mode archive.
- Buyer
- Neurocrine Biosciences, Inc.
- Target
- Soleno Therapeutics, Inc.
- Deal value
- Not disclosed
- Deal type
- going private